UK study tracks Real-World impact of nerve stimulation on epilepsy
NCT ID NCT04779814
First seen Mar 29, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study observed 97 people with drug-resistant epilepsy in the UK who had a vagus nerve stimulation (VNS) device implanted. Researchers used medical records and patient surveys to see how the therapy affected hospital visits and seizure control over time. The goal was to understand real-world outcomes, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bristol Royal Hospital For Children
Bristol, United Kingdom
-
Nottingham Children's Hospital
Nottingham, United Kingdom
-
Oxford University Hospital NHSFT
Oxford, United Kingdom
-
Queen Elizabeth Hospital Birmingham
Birmingham, United Kingdom
-
The Walton Centre
Liverpool, United Kingdom
Conditions
Explore the condition pages connected to this study.